2nd Annual Obesity & Cardiometabolic Innovation Forum

2nd Annual Obesity & Cardiometabolic Innovation Forum

CONNECTING OBESITY, DIABETES & CARDIOMETABOLIC BREAKTHROUGHS

5th of June 2026|ROYAL SONESTA NEW ORLEANS | USA

We are pleased to welcome you to the 2nd Annual Obesity & Cardiometabolic Innovation Forum (#Sachs_OCIF)

The programme is designed to address the latest breakthroughs shaping the future of obesity, diabetes, and cardiometabolic care. Hear from leading experts, explore emerging therapies and technologies, and gain actionable insights on investment and deal-making in this rapidly evolving field. Join a programme designed to connect science, strategy, and next-generation innovation. 

The 2nd Annual OCIF is taking place on the 5th of June at the Royal Sonesta New Orleans. The event precedes the American Diabetes Association’s (ADA's) 2026 Scientific Sessions, with virtual meetings scheduled for the 16th - 17th of June. The physical programme consists of panels and keynotes taking place in the South Ballroom, which will be made available on demand for virtual participants from the 16th of June. Additionally, there are pre-arranged in-person meetings, up to 15 live and on-demand company showcases, and a reception in the evening.  

On the Event Portal, you have access to all the information related to the event. In the navigation bar on the left, you can see all the event’s tabs, including the agenda, FAQ, venue details, link to your networking account, list of attendees and investors, as well as speakers, presenters, sponsors, and supporters’ profiles. When you click on the tab ‘PRESENTERS’ you will be able to view companies with their profiles.  

To access your Online Meeting System Account, please click on the ‘NETWORKING’ tab. Once you click on the button ‘MY ACCOUNT’, a new window will open where you can manage your schedule, message participants, plan meetings, and connect with others during the event. The in-person meetings will take place on the 5th of June, while virtual meetings will take place on the 16th – 17th of June. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as an option to present slides using a screen share function, and in-person meetings will take place in the North Ballroom. Should you have any queries about your schedule, the Sachs team situated by the registration table is available for your assistance. 

The registration desk opens at 7:30 AM (CDT) on the 5th of June. The programme begins at 8:30 AM (CDT). For on-site registration, we ask you to present a photo ID. There will be a networking lunch, reception, and coffee stations set up in the rooms throughout the event. For wireless internet connection, please connect to ‘Sonesta_Conference’ network using password ‘Sonesta2026’. 

If you have any issues, please contact our support team using the LIVE CHAT icon in the bottom right corner of the screen. If you are at the venue, come to the registration helpdesk, and one of our team members will assist you.  

SILVER SPONSOR:

​Fenix Group International, LLC

Panels & Sessions on the 5th of June Include:

  • Fireside Chat: "Ken & Matt on the Future of Obesity"
  • State of the Markets & BioPharma Dealmaking Panel
  • Fireside Chat: "Beyond the Injection: Advancing Next Era of Oral GLP-1RAs & Cardiometabolic Therapies"
  • Unmet Needs & Next-Gen Therapeutics for Obesity Panel
  • Platform Technologies Panel: Obesity Management, Going Beyond BMI
  • Introductory Speech by Mayo Clinic
  • Personalized Approaches Panel: Precision & Combination Therapies
  • Investing in Healthy Lifespan & Metabolic Health Panel
  • Concluding Comments

In-Person Meetings:

  • 5th of June: 9:00 AM - 4:00 PM (CDT)

Online Virtual Meetings:

  • 16th – 17th of June: 8:00 AM – 6:00 PM (EDT)

Reception:

  • 5th of June: 4:00 PM - 5:00 PM (CDT)

Keynote Speakers:

Andres Acosta
Andres Acosta
Director of Nutrition Obesity Program & Associate Professor of Medicine, Mayo Clinic
David Risinger
David Risinger
Senior Managing Director, Diversified Biopharmaceuticals Research, Leerink Partners LLC
Jay Olson
Jay Olson
Managing Director & Senior Analyst, Oppenheimer & Co. Inc.
Kenneth Custer
Kenneth Custer
EVP & President, Lilly Cardiometabolic Health, Eli Lilly and Company
Matthew Maryniak
Matthew Maryniak
President, Fenix Group International, LLC
Ting (Tim) Xiao
Ting (Tim) Xiao
CFO, Eccogene Inc.

Chairs & Speakers:

Andres Acosta
Andres Acosta
Director of Nutrition Obesity Program & Associate Professor of Medicine, Mayo Clinic
Anna Jen Beuchat
Anna Jen Beuchat
Director Business Development, F. Hoffmann-La Roche AG
Bei Zhang
Bei Zhang
Global Scientific Advisor, R&D External Innovation, Novo Nordisk A/S
Benjamin Yaden
Benjamin Yaden
Vice President - External Innovation-Cardiometabolic Health, Women's Health & Healthy Aging , Eli Lilly and Company
Blythe Sather
Blythe Sather
SVP Head of Research, Tune Therapeutics
Brady Miller
Brady Miller
Director & Head of Syndicated Services, Fenix Group International, LLC
Brian Bloomquist
Brian Bloomquist
Chief Business & Strategy Officer, Alveus Therapeutics, Inc.
Christopher Stern
Christopher Stern
Managing Director, L.E.K. Consulting
David Kendall
David Kendall
Chief Medical Officer, Zealand Pharma A/S
David Risinger
David Risinger
Senior Managing Director, Diversified Biopharmaceuticals Research, Leerink Partners LLC
Erik Ingelsson
Erik Ingelsson
Chief Scientific Officer, Wave Life Sciences
Frederick Beddingfield
Frederick Beddingfield
CEO & Director, Rubedo Life Sciences
Harry Robb
Harry Robb
Principal, Lifespan Vision Ventures LLC
Jamie Coleman
Jamie Coleman
Chief Commercial Officer, Kailera Therapeutics
Jay Olson
Jay Olson
Managing Director & Senior Analyst, Oppenheimer & Co. Inc.
Joel Sandler
Joel Sandler
Associate Partner, Ipsos Healthcare Advisory Service
John Westwood
John Westwood
Senior Vice President, Strategy Consulting, Lumanity
Jon Rees
Jon Rees
CEO, MitoRx Therapeutics
Jyothis George
Jyothis George
Chief Medical Officer, NodThera, Inc.
Kevin Slawin
Kevin Slawin
Founder & CEO, Eos SENOLYTIX, Inc.
Laurent Audoly
Laurent Audoly
Founder & CEO, PriveBio, Inc.
Lloyd Diamond
Lloyd Diamond
CEO & Board Member, Nitinotes Surgical
Mads Tang-Christensen
Mads Tang-Christensen
Chief Scientific Officer, Antag Therapeutics
Marija Mavar
Marija Mavar
President, Pharma Solutions, Perspectum Ltd.
Melissa Jones
Melissa Jones
Director, Metabolic Disorders, Foundation for the National Institutes of Health (FNIH)
Michael Rice
Michael Rice
Expert Advisor, SVP, Cell & Gene Therapy, Lumanity
Olivier Soula
Olivier Soula
Co-Founder & CEO, ADOCIA
Paul Rubin
Paul Rubin
Chief Medical Officer, BioAge Labs, Inc.
Robert Augustin
Robert Augustin
Director Strategic Partnering Cardiorenalmetabolism, Global BD&L, Boehringer Ingelheim International GmbH
Steve Dickman
Steve Dickman
CEO, CBT Advisors
Yury Kukushkin
Yury Kukushkin
Investment Partner, Hevolution

Participation Options:

Complimentary passes are provided for qualified institutional (buy/sell-side), private equity, and venture investors. The number of passes is limited, and priority is given to regular participants, however, the organiser has the discretion to reject registrations. Other participants may consider purchasing access, which includes in-person or virtual participation, with different options to showcase your company.  

Presenting Companies:

Alphala Co., Ltd. logo
Alveus Therapeutics, Inc. logo
Amgen, Inc. logo
Eos SENOLYTIX, Inc. logo
MitoRx Therapeutics logo
Nitinotes Surgical logo
Perspectum Ltd. logo
PriveBio, Inc. logo
Rivus Pharmaceuticals, Inc. logo

Previous Highlights:

2nd Annual Obesity & Cardiometabolic Innovation Forum event highlight
2nd Annual Obesity & Cardiometabolic Innovation Forum event highlight
2nd Annual Obesity & Cardiometabolic Innovation Forum event highlight
2nd Annual Obesity & Cardiometabolic Innovation Forum event highlight
2nd Annual Obesity & Cardiometabolic Innovation Forum event highlight

To learn more about presenting, exhibiting or sponsorship opportunities, please contact us at [email protected] or call us on + 44 203 463 4890.

SACHS ASSOCIATES SWITZERLAND AG

Aeschenvorstadt 4
Basel | CH-4051
Switzerland

SACHS ASSOCIATES LTD.

3rd floor, 89-90 Paul Street
London | EC2A 4NE
United Kingdom
Privacy Policy

© COPYRIGHT 2026. ALL RIGHTS RESERVED.